Bio€quity Europe 2023
14-16 May, 2023 | Convention Centre Dublin | Ireland
Get in touch with the ICON team at Bio€quity Europe.
We invite you to explore the resources we have assembled below, to demonstrate how we support biotechs and help you meet your critical milestones.
-
Blog: Uncertainty to opportunity - Recent trends in the biotech funding environment
In this blog, discover more about how the biotech sector is transforming uncertainty into opportunity.
-
Blog: Crafting a competitive biotech funding pitch
Biotechs can hone their pitch with the guidelines provided in this blog and through early engagement opportunities with strategic partners.
-
Blog: Optimising biotech trial designs to stretch your cash runway
Read this blog to learn a few key considerations to help optimise and de-risk your trial design.
-
Blog: The importance of developing rTPP to build biotech asset value
Discover how Biotechs can build value into their asset by developing a reimbursable Target Product Profile (rTPP).
-
Blog: Exploring the benefits of biotech partnerships
The biotechnology sector is leading the way in developing innovative therapies that will address the unmet needs of many challenging diseases.
-
Media article: Due diligence and beyond
Dr. Sandra Eagle outlines how due diligence has evolved from a discrete standalone technical assessment, to now being an integrated part of the holistic development continuum of an asset.
-
Media article: Europe’s emerging biotechs
John Macdonald, Vice President, Venture & Financial Alliances, examines the European biotech sector – its expertise and opportunities, and potential for growth.
-
Media article: Biotech funding
ICON plc has partnered with ALSA Ventures I SCSp, a Europe focused therapeutic venture capital fund, to accelerate early clinical development within the UK and the EU.
.jpg?h=240&itok=yw3Uql_W "Case_Study_Externalised_Development-(1).jpg"){kind=icon}
Meet Our Experts
Arrange a meeting with us to discuss your further requirements